Screener
Zymeworks ZYME Compensation and benefits
Discontinued — last reported Q1 '26
Compensation and benefits at other companies
Segments
By segment
Other financials
Where this comes from
Reported directly by Zymeworks in its filing.
Tagged under the XBRL concept us-gaap:ShareBasedCompensation.
The source filing: Zymeworks’s 10-Q, filed May 7, 2026.
- Filed
- May 7, 2026, 4:15 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001937653-26-000034
| Line item | Three Months Ended March 31, 2026 | Three Months Ended March 31, 2025 |
|---|---|---|
| Adjustments to reconcile net income to net cash provided by operating activities: | ||
| Depreciation of property and equipment | 963 | 981 |
| Amortization of intangible assets | 176 | 1,617 |
| Stock-based compensation expense | 6,935 | 6,402 |
| Amortization of operating lease right-of-use assets | 1,708 | 707 |
| Amortization of debt issuance costs | 26 | — |
| Non-cash interest expense related to sale of royalties | 2,040 | — |
| Deferred income tax recovery | (2,200) | (410) |
Item 1. Financial Statements
FAQ
- What is Zymeworks's compensation and benefits?
- Zymeworks (ZYME) reported compensation and benefits of $6.94M in Q1 2026.
- How has Zymeworks's compensation and benefits changed year-over-year?
- Zymeworks's compensation and benefits increased by 8.3% year-over-year, from $6.4M to $6.94M.
- What does compensation and benefits mean?
- Total employee-related costs including salaries, wages, bonuses, commissions, stock-based compensation, health insurance, retirement contributions, and payroll taxes.
Ask your AI about Zymeworks's compensation and benefits.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude